Solubility enhancement and in vitro evaluation of PEG-b-PLA micelles as nanocarrier of semi-synthetic andrographolide analogue for cholangiocarcinoma chemotherapy

References

• Das B, Chowdhury C, Kumar D, et al. Synthesis, cytotoxicity, and structure–activity relationship (SAR) studies of andrographolide analogues as anti-cancer agent. Bioorg Med Chem Lett 2010;20:6947–6950
   PubMed Web of Science ®Google Scholar
• Sirion U, Kasemsook S, Suksen K, et al. New substituted C-19-andrographolide analogues with potent cytotoxic activities. Bioorg Med Chem Lett 2012;22:49–52
   PubMed Web of Science ®Google Scholar
• Bhummaphan N, Nateewattana J, Suksen K, et al. Induction of cholangiocarcinoma cells apoptosis by an andrographolide analog. Sci Res Essays 2013;8:26–31
   Google Scholar
• Liebmann J, Cook J, Lipschultz C, et al. Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Br J Cancer 1993;68:1104
   PubMed Web of Science ®Google Scholar
• Hahnvajanawong C, Bhudisawadi V, Namwat N, et al. Comparative in vitro cytotoxicity of the generic and reference products of gemcitabine on various cancer cell lines. Srinagarind Med J 2013;26:2–8
   Google Scholar
• Namwat N, Sripa B, Loilome W, et al. Comparison of Italic cytoxicity of generic paclitaxel and irinotecan formulations with their reference formulations on seven human intrahepatic cholangiocarcinoma cell lines. Srinagarind Med J 2013;22:230–234
   Google Scholar
• Greco K, Bogner R. Solution-mediated phase transformation: significance during dissolution and implications for bioavailability. J Pharm Sci 2012;101:2996–3018
   PubMed Web of Science ®Google Scholar
• Sutton D, Wang S, Nasongkla N, et al. Doxorubicin and β-lapachone release and interaction with micellar core materials: experiment and modeling. Exp Biol Med 2007;232:1090–1099
   PubMed Web of Science ®Google Scholar
• Mohan P, Rapoport N. Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking. Mol Pharm 2010;7:1959–1973
   PubMed Web of Science ®Google Scholar
• Serajuddin A. Salt formation to improve drug solubility. Adv Drug Deliv Rev 2007;59:603–616
   PubMed Web of Science ®Google Scholar
• Phuengkham H, Teeranachaideekul V, Chulasiri M, Nasongkla N. Preparation and optimization of chlorophene-loaded nanospheres as controlled release antimicrobial delivery systems. Pharm Dev Technol 2014:1–6. doi: 10.3109/10837450.2014.959180
   PubMed Web of Science ®Google Scholar
• Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001;47:113–131
   PubMed Web of Science ®Google Scholar
• Blanco E, Bey EA, Dong Y, et al. β-Lapachone-containing PEG–PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells. J Control Release 2007;122:365–374
   PubMed Web of Science ®Google Scholar
• Cabral H, Matsumoto Y, Mizuno K, et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol 2011;6:815–823
   PubMed Web of Science ®Google Scholar
• Dehghan Kelishady P, Saadat E, Ravar F, et al. Pluronic F127 polymeric micelles for co-delivery of paclitaxel and lapatinib against metastatic breast cancer: preparation, optimization and in vitro evaluation. Pharm Dev Technol 2014:1–9. doi: 10.3109/10837450.2014.965323
   PubMed Web of Science ®Google Scholar
• Khamlao W, Hongeng S, Sakdapipanich J, Nasongkla N. Preparation of self-solidifying polymeric depots from PLEC-PEG-PLEC triblock copolymers as an injectable drug delivery system. J Polym Res 2012;19:1–12
   Web of Science ®Google Scholar
• Qiu L, Zhang L, Zheng C, Wang R. Improving physicochemical properties and doxorubicin cytotoxicity of novel polymeric micelles by poly (ɛ-caprolactone) segments. J Pharm Sci 2011;100:2430–2442
   PubMed Web of Science ®Google Scholar
• Chen H, Khemtong C, Yang X, et al. Nanonization strategies for poorly water-soluble drugs. Drug Discov Today 2011;16:354–360
   PubMed Web of Science ®Google Scholar
• Ebrahimi E, Khandaghi AA, Valipour F, et al. In vitro study and characterization of doxorubicin-loaded magnetic nanoparticles modified with biodegradable copolymers. Artif Cells Nanomed Biotechnol 2014:1–9. doi: 10.3109/21691401.2014.968822
   Web of Science ®Google Scholar
• Nasongkla N, Shuai X, Ai H, et al. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem 2004;116:6483–6487
   Google Scholar
• Nasongkla N, Bey E, Ren J, et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett 2006;6:2427–2430
   PubMed Web of Science ®Google Scholar
• Theerasilp M, Nasongkla N. Comparative studies of poly (ɛ-caprolactone) and poly (D, L-lactide) as core materials of polymeric micelles. J Microencapsul 2012;30:390–397
   PubMed Web of Science ®Google Scholar
• Xiao RZ, Zeng ZW, Zhou GL, et al. Recent advances in PEG–PLA block copolymer nanoparticles. Int J Nanomed 2010;5:1057
   PubMed Web of Science ®Google Scholar
• Pozzi G, Ghetti P, Balsamo G, et al. Crystalline irinotecan hydrochloride and methods for the preparation thereof. US Patents. US 8,247,426 B2; Aug. 21; 2012:1–3
   Google Scholar
• Cheng J, Teply BA, Sherifi I, et al. Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 2007;28:869–876
   PubMed Web of Science ®Google Scholar
• Shuai X, Ai H, Nasongkla N, et al. Micellar carriers based on block copolymers of poly (ɛ-caprolactone) and poly (ethylene glycol) for doxorubicin delivery. J Control Release 2004;98:415–426
   PubMed Web of Science ®Google Scholar
• Uddin MN, Ahmed I, Roni MA, et al. In vitro release kinetics study of ranolazine from swellable hydrophilic matrix tablets. Dhaka Univ J Pharm Sci 2009;8:31–38
   Google Scholar
• ChemAxon. Available from: http://www.chemaxon.com/products/marvin/ [last accessed 20 January 2015]
   Google Scholar
• Mobarak DH, Salah S, Elkheshen SA. Formulation of ciprofloxacin hydrochloride loaded biodegradable nanoparticles: optimization of technique and process variables. Pharm Dev Technol 2013;19:891–900
   PubMed Web of Science ®Google Scholar
• Ye YQ, Chen FY, Wu Qa, et al. Enhanced cytotoxicity of core modified chitosan based polymeric micelles for doxorubicin delivery. J Pharm Sci 2009;98:704–712
   PubMed Web of Science ®Google Scholar
• Kedar U, Phutane P, Shidhaye S, Kadam V. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomed Nanotechnol Biol Med 2010;6:714–729
   PubMed Web of Science ®Google Scholar
• Ebrahim Attia AB, Ong ZY, Hedrick JL, et al. Mixed micelles self-assembled from block copolymers for drug delivery. Curr Opin Colloid Interface Sci 2011;16:182–194
   Web of Science ®Google Scholar
• Letchford K, Burt H. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm 2007;65:259–269
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000;65:271–284
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011;63:136–151
   PubMed Web of Science ®Google Scholar
• Lee J, Cho EC, Cho K. Incorporation and release behavior of hydrophobic drug in functionalized poly (D, L-lactide)-block–poly (ethylene oxide) micelles. J Control Release 2004;94:323–335
   PubMed Web of Science ®Google Scholar
• Cheng Z, Al Zaki A, Hui JZ, et al. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 2012;338:903–910
   PubMed Web of Science ®Google Scholar
• Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery. J Pharm Sci 2003;92:1343–1355
   PubMed Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1–20
   PubMed Web of Science ®Google Scholar
• Gref R, Quellec P, Sanchez A, et al. Development and characterization of CyA-loaded poly (lactic acid)–poly (ethylene glycol) PEG micro-and nanoparticles. Comparison with conventional PLA particulate carriers. Eur J Pharm Biopharm 2001;51:111–118
   PubMed Web of Science ®Google Scholar
• Quellec P, Gref R, Dellacherie E, et al. Protein encapsulation within poly (ethylene glycol)-coated nanospheres. II. Controlled release properties. J Biomed Mater Res 1999;47:388–395
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang C, Gong C, et al. Polysorbate 80 coated poly (ɛ-caprolactone)–poly (ethylene glycol)–poly (ɛ-caprolactone) micelles for paclitaxel delivery. Int J Pharm 2012;434:1–8
   PubMed Web of Science ®Google Scholar
• Li Y, Xu X, Shen Y, et al. Preparation and evaluation of copolymeric micelles with high paclitaxel contents and sustained drug release. Colloids Surf A Physicochem Eng Aspects 2013;429:12–18
   Web of Science ®Google Scholar
• Hashem FM, Nasr M, Khairy A. In vitro cytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate. Pharm Dev Technol 2013;19:824–832
   PubMed Web of Science ®Google Scholar